Real-world Evaluation of Healthcare Resource Use and Costs in elder patients with Nonvalvular Atrial Fibrillation Treated With Apixaban vs. Warfarin in the US: A Retrospective Study
Latest Information Update: 17 Jun 2017
Price :
$35 *
At a glance
- Drugs Apixaban (Primary) ; Warfarin (Primary)
- Indications Embolism and thrombosis
- Focus Therapeutic Use
- 20 May 2017 Results presented at the 2017 Annual Scientific Meeting of the American Geriatrics Society
- 16 Nov 2016 Results presented at the 89th Annual Scientific Sessions of the American Heart Association